Deeper Dive: Understanding Cg Oncology Inc. (CGON) Through its Various Ratios

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Cg Oncology Inc. (NASDAQ: CGON) closed at $38.34 in the last session, down -1.69% from day before closing price of $39.00. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 1.09 million shares were traded. CGON stock price reached its highest trading level at $40.0 during the session, while it also had its lowest trading level at $38.16.

Ratios:

We take a closer look at CGON’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 47.57 and its Current Ratio is at 47.57. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on Sep-24-24, initiated with a Outperform rating and assigned the stock a target price of $66.

On August 28, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $65.

On June 28, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $65.BofA Securities initiated its Buy rating on June 28, 2024, with a $65 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 29 ’24 when Song Hong Fang sold 650,455 shares for $35.36 per share. The transaction valued at 23,000,089 led to the insider holds 586,982 shares of the business.

Unique Diamond Investments Ltd bought 424,210 shares of CGON for $15,000,000 on Aug 29 ’24. On Aug 29 ’24, another insider, Charming Jade Ltd, who serves as the Director of the company, bought 226,245 shares for $35.36 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2571732224 and an Enterprise Value of 2019207936. Its current Enterprise Value per Revenue stands at 3746.211 whereas that against EBITDA is -29.616.

Stock Price History:

Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is 8.73%, while the 200-Day Moving Average is calculated to be 5.34%.

Shares Statistics:

According to the various share statistics, CGON traded on average about 738.42K shares per day over the past 3-months and 1708790 shares per day over the past 10 days. A total of 66.64M shares are outstanding, with a floating share count of 40.23M. Insiders hold about 40.02% of the company’s shares, while institutions hold 47.97% stake in the company. Shares short for CGON as of 1724976000 were 6197518 with a Short Ratio of 8.39, compared to 1722384000 on 6839556. Therefore, it implies a Short% of Shares Outstanding of 6197518 and a Short% of Float of 9.33.

Most Popular